Evidence map›Paper›PMID 41209561›Full record

ArticleInternational journal of medical sciences2025

Risk-based screening and prognostic analysis for second primary malignancies in kidney cancer patients: a retrospective cohort study based on large-scale population and Mendelian randomization analysis.

Mingrui Zou, Ruiyi Deng, Haode Liu, Jianhui Qiu, Peidong Tian, Jiaheng Shang, Jingcheng Zhou, Xueying Li, Lin Cai, Yizhou Wang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mingrui ZouDepartment of Urology, Peking University First Hospital, Beijing, China.
Ruiyi DengDepartment of Urology, Peking University First Hospital, Beijing, China.
Haode LiuDepartment of Urology, Peking University First Hospital, Beijing, China.
Jianhui QiuDepartment of Urology, Peking University First Hospital, Beijing, China.
Peidong TianDepartment of Urology, Peking University First Hospital, Beijing, China.
Jiaheng ShangDepartment of Urology, Peking University First Hospital, Beijing, China.
Jingcheng ZhouDepartment of Urology, Peking University First Hospital, Beijing, China.
Xueying LiDepartment of Statistics, Peking University First Hospital, Beijing, China.
Lin CaiDepartment of Urology, Peking University First Hospital, Beijing, China.
Yizhou WangDepartment of Central Laboratory, Peking University First Hospital, Beijing, China.
Kan GongDepartment of Urology, Peking University First Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Kidney NeoplasmsNeoplasms, Second PrimaryAgedEarly Detection of CancerFemaleHumansIncidenceMaleMendelian Randomization AnalysisMiddle AgedNomogramsPrognosisRetrospective StudiesRisk AssessmentRisk FactorsSEER ProgramKidney cancerMendelian randomizationPrognosisRisk factorsSecond primary malignancy

Identifiers

PMID41209561
PMCPMC12595329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.